Literature DB >> 29780730

Robotic left lower sleeve lobectomy with bronchoplasty for the removal of a carcinoid tumour.

Gerald J S Tan1, Jun Shang Poon1, Paul L Z Khoo1, Andrel W H Yoong2, Marco Nardini3, Joel Dunning4.   

Abstract

Lung carcinoid tumours constitute approximately 1-2% of all pulmonary tumours. They are derived from enterochromaffin cells, which are also known as 'Kulchitsky cells' and generally have indolent growth and development patterns. Carcinoid tumours are categorized as typical or atypical, depending on the number of mitoses per high power field and the presence of necrosis. In terms of management, surgical resection has been recognized to be the standard treatment for pulmonary carcinoid tumours. To our knowledge, the da Vinci system and robotic surgery have not been applied in sleeve lobectomies and bronchoplasty for the removal of carcinoid tumours in the United Kingdom. Therefore, we present a case of a sleeve lobectomy with bronchoplasty procedure for the removal of a carcinoid tumour located in the left lower lobe of the patient. The bronchus was repaired using a V-lock suture & Prolene sutures with the surgery performed using the da Vinci robotic surgical system.

Entities:  

Keywords:  Carcinoid tumour; bronchoplasty; minimally invasive surgery; robotic surgery

Year:  2018        PMID: 29780730      PMCID: PMC5945663          DOI: 10.21037/jovs.2018.04.06

Source DB:  PubMed          Journal:  J Vis Surg        ISSN: 2221-2965


  4 in total

1.  Consensus statement on definitions and nomenclature for robotic thoracic surgery.

Authors:  Robert Cerfolio; Brian E Louie; Alexander S Farivar; Mark Onaitis; Bernard J Park
Journal:  J Thorac Cardiovasc Surg       Date:  2017-05-23       Impact factor: 5.209

2.  Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung.

Authors:  Koji Tsuta; Maria G Raso; Neda Kalhor; Diane D Liu; Ignacio I Wistuba; Cesar A Moran
Journal:  Lung Cancer       Date:  2010-05-11       Impact factor: 5.705

3.  Neuroendocrine neoplasms of the lung: a prognostic spectrum.

Authors:  Hisao Asamura; Toru Kameya; Yoshihiro Matsuno; Masayuki Noguchi; Hirohito Tada; Yuichi Ishikawa; Tomoyuki Yokose; Shi-Xu Jiang; Takeshi Inoue; Ken Nakagawa; Kinuko Tajima; Kanji Nagai
Journal:  J Clin Oncol       Date:  2006-01-01       Impact factor: 44.544

4.  Lung carcinoid tumor biology: treatment and survival.

Authors:  J Dahabreh; G P Stathopoulos; J Koutantos; S Rigatos
Journal:  Oncol Rep       Date:  2009-03       Impact factor: 3.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.